185 related articles for article (PubMed ID: 32665994)
1. Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study.
Mao S; Wu Y; Wang R; Guo Y; Yuan J; Zhang W; Zhang J; Yan Y; Yao X
Investig Clin Urol; 2020 Jul; 61(4):382-389. PubMed ID: 32665994
[TBL] [Abstract][Full Text] [Related]
2. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.
Mason RJ; Frank I; Bhindi B; Tollefson MK; Thompson RH; Karnes RJ; Tarrell R; Thapa P; Boorjian SA
World J Urol; 2017 Dec; 35(12):1879-1884. PubMed ID: 28913657
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Soave A; John LM; Dahlem R; Minner S; Engel O; Schmidt S; Kluth LA; Fisch M; Rink M
Urology; 2015 Jul; 86(1):92-8. PubMed ID: 26051839
[TBL] [Abstract][Full Text] [Related]
4. Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.
Voskuilen CS; Seiler R; Rink M; Poyet C; Noon AP; Roghmann F; Necchi A; Aziz A; Lavollé A; Young MJ; Marks P; Saba K; van Rhijn BWG; Fransen van de Putte EE; Ablat J; Black PC; Sosnowski R; Dobruch J; Kumar P; Jallad S; Catto JWF; Xylinas E; Hendricksen K;
Eur Urol Focus; 2020 Nov; 6(6):1226-1232. PubMed ID: 30559065
[TBL] [Abstract][Full Text] [Related]
5. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
Wang JK; Boorjian SA; Cheville JC; Kim SP; Tarrell RF; Thapa P; Frank I
World J Urol; 2012 Dec; 30(6):801-6. PubMed ID: 23132611
[TBL] [Abstract][Full Text] [Related]
6. Restrictive transfusion in radical cystectomy is safe.
Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S
Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
[TBL] [Abstract][Full Text] [Related]
7. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.
Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S
Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867
[TBL] [Abstract][Full Text] [Related]
8. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
Bruins HM; Arends TJ; Pelkman M; Hulsbergen-van de Kaa CA; van der Heijden AG; Witjes JA
Clin Genitourin Cancer; 2014 Jun; 12(3):190-5. PubMed ID: 24332508
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
10. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
[TBL] [Abstract][Full Text] [Related]
11. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.
Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782
[TBL] [Abstract][Full Text] [Related]
12. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
Diamantopoulos LN; Sekar RR; Holt SK; Khaki AR; Miller NJ; Gadzinski A; Nyame YA; Vakar-Lopez F; Tretiakova MS; Psutka SP; Gore JL; Lin DW; Schade GR; Hsieh AC; Lee JK; Yezefski T; Schweizer MT; Cheng HH; Yu EY; True LD; Montgomery RB; Grivas P; Wright JL
Urol Oncol; 2021 Aug; 39(8):496.e1-496.e8. PubMed ID: 33551249
[TBL] [Abstract][Full Text] [Related]
13. Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Outcome and Survival: An Observational Cohort Study.
Furrer MA; Fellmann A; Schneider MP; Thalmann GN; Burkhard FC; Wuethrich PY
Eur Urol Focus; 2018 Dec; 4(6):916-923. PubMed ID: 28951117
[TBL] [Abstract][Full Text] [Related]
14. Decrease of Preoperative Serum Albumin-to-Globulin Ratio as a Prognostic Indicator after Radical Cystectomy in Patients with Urothelial Bladder Cancer.
Oh JS; Park DJ; Byeon KH; Ha YS; Kim TH; Yoo ES; Kwon TG; Kim HT
Urol J; 2021 Jan; 18(1):66-73. PubMed ID: 33515214
[TBL] [Abstract][Full Text] [Related]
15. Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival.
Volz Y; Grimm T; Ormanns S; Eismann L; Pfitzinger PL; Jokisch JF; Schulz G; Casuscelli J; Schlenker B; Karl A; Stief CG; Kretschmer A
Urol Oncol; 2021 May; 39(5):299.e15-299.e21. PubMed ID: 33187885
[TBL] [Abstract][Full Text] [Related]
16. Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis.
Knoedler JJ; Boorjian SA; Kim SP; Weight CJ; Thapa P; Tarrell RF; Cheville JC; Frank I
J Urol; 2012 Oct; 188(4):1115-9. PubMed ID: 22901583
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
18. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
[TBL] [Abstract][Full Text] [Related]
19. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
[TBL] [Abstract][Full Text] [Related]
20. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
